<ѻýҕl>Hippocampus-Sparing Radiation a New Option in Brain Mets Patientsѻýҕl> Approach preserved cognitive function, but patient prognosis a key consideration Oct 24, 2018
<ѻýҕl>Black Race Not Associated with Worse Prostate Ca Outcomesѻýҕl> Results contrast with past population registry data Oct 24, 2018 video
<ѻýҕl>First-Line Anti-PD-1 Ups Survival for Advanced Head/Neck Cancerѻýҕl> Pembrolizumab, with or without chemo, tops current standard Oct 24, 2018
<ѻýҕl>SABR Equally Effective in RCC Patients With One or Both Kidneysѻýҕl> Minimal side effects reported with high-dose treatment Oct 23, 2018
<ѻýҕl>Cetuximab Fails Twice vs Cisplatin for HPV-Related Oral Caѻýҕl> Cetuximab resulted in more patient deaths across U.S., German studies Oct 23, 2018
<ѻýҕl>Liquid Biopsy Rules Out Relapse in HPV-Positive Oral Caѻýҕl> Test had 100% negative predictive value Oct 23, 2018
<ѻýҕl>Combination Slows Advanced RCCѻýҕl> Avelumab-axitinib beneficial, irrespective of PD-L1 status Oct 23, 2018
<ѻýҕl>Nearly 90% Free of Prostate Ca Progression With ADT, Pelvic Node RTѻýҕl> Data also showed trend toward reduction in distant metastases Oct 22, 2018
<ѻýҕl>Ethoxyquin Analogue May Prevent Chemotherapy Nerve Damageѻýҕl> Modified agent prevented nerve fiber loss and sensory changes in animal models Oct 22, 2018
<ѻýҕl>Aggressive RT, Surgery Doubles OS in NSCLC With Limited Metsѻýҕl> If new drug produced such a response it would make "millions," said expert Oct 22, 2018 video
<ѻýҕl>Prostate RT Ups Overall Survival in Metastatic Diseaseѻýҕl> Benefit limited to men with low disease burden Oct 22, 2018
<ѻýҕl>PI3K Inhibitor Doubles PFS in HR+/HER2- Breast Cancerѻýҕl> Benefit limited to patients with PIK3CA mutations Oct 22, 2018
<ѻýҕl>No Increase in Late Effects With Weekly RT in Breast Caѻýҕl> 10-year data show low rate of late-onset effects with 28.5 Gy regimen Oct 21, 2018
<ѻýҕl>RT Add-On Boosts Outcomes in 'Low-Risk' DCIS Breast Caѻýҕl> Highest benefit seen in patients who also used tamoxifen Oct 21, 2018
<ѻýҕl>Practice-Changing PARP Inhibitor Study in Ovarian Cancerѻýҕl> "Unprecedented" increase in PFS with upfront olaparib maintenance Oct 21, 2018
<ѻýҕl>Immunotherapy Wins in Triple-Negative Breast Cancerѻýҕl> Atezolizumab-chemo combo extends PFS, OS in metastatic disease Oct 21, 2018
<ѻýҕl>Adding Radium-223 to Abiraterone No Help in Prostate Caѻýҕl> More fractures, deaths in patients with mCRPC and bone mets Oct 20, 2018
<ѻýҕl>FDA Rejects Canakinumab in CVD Preventionѻýҕl> CANTOS data not enough to expand indication Oct 19, 2018
<ѻýҕl>Morning Break: Human Side of Addiction; Eyeing Da Vinci's Genius; No CV Indication for Ilarisѻýҕl> Health news and commentary from around the Web gathered by the ѻýҕl staff Oct 19, 2018
<ѻýҕl>No 'Sound Science' Behind Avoiding Topical Agents Before RTѻýҕl> Increased dose to skin only seen when applying 'copious' amounts Oct 18, 2018
<ѻýҕl>SBRT Doubles 5-Year Survival in Oligometastatic Cancersѻýҕl> Most patients in phase II trial had up to three metastatic lesions Oct 17, 2018
<ѻýҕl>Nerve Plane Block May Improve Mastectomy Painѻýҕl> Also: obese children and post-surgery pain; patient-controlled epidurals after C-section Oct 16, 2018
<ѻýҕl>Alternative Therapies Popular With Sarcoma Patientsѻýҕl> Drug-drug interactions still poorly understood Oct 11, 2018
<ѻýҕl>Lung Screening Saves Lives, but Who Should Be Screened?ѻýҕl> Experts debate controversial screening issues in meeting "Smackdown" Oct 11, 2018
<ѻýҕl>Inherited JAK3 Mutation May Up Head/Neck Ca Risk in African Americansѻýҕl> About 8% carry the single nucleotide polymorphism Oct 11, 2018
<ѻýҕl>Knowledge Gaps on HPV's Link to Head/Neck Ca for Docs in Trainingѻýҕl> Few are equipped to perform HPV vaccine counseling, study found Oct 10, 2018
<ѻýҕl>SSA Transition Safe, Effective for NETsѻýҕl> Long-term survival, cost-effectiveness examined in other studies Oct 09, 2018
<ѻýҕl>Molecular Profiling Can ID Cancer Risk in Thyroid Lesionsѻýҕl> In lesions with atypia, different mutations confer higher and lower risks Oct 09, 2018
<ѻýҕl>Surgery Improves Survival for most pNETsѻýҕl> Mortality odds 70%-80% lower for all but stage I disease Oct 06, 2018
<ѻýҕl>ACG: Focus on the Practical at Annual Meetingѻýҕl> Topics will range from gluten contamination to artificial intelligence for polyp detection Oct 05, 2018
<ѻýҕl>Lung Cancer Screening Rates Fall Short in VAѻýҕl> Adherence was 77% among those with negative baseline screens Oct 04, 2018
<ѻýҕl>Deaths from Non-Obesity-Related Cancers Higher in T2Dѻýҕl> Even in some obesity-related malignancies, high BMI was inversely tied to cancer death Oct 03, 2018
<ѻýҕl>Sickle Cell in the ED: Old Therapies, New Strategiesѻýҕl> With treatments unchanged in decades, docs seek to improve delivery Oct 02, 2018
<ѻýҕl>Mastectomy Not the Only Option in Extensive DCISѻýҕl> Lumpectomy plus RT viable if risks, benefits are explained Sep 28, 2018
<ѻýҕl>More Evidence that Screening Cuts Lung Cancer Deathsѻýҕl> Significantly lower risk in men and women Sep 26, 2018
<ѻýҕl>Newer ALK Inhibitor Tops Standard in NSCLCѻýҕl> Significant improvement in PFS with brigatinib after short follow-up Sep 26, 2018
<ѻýҕl>Docs Need to Discuss Money Matters with Cancer Patientsѻýҕl> Breast cancer, older patients report high levels of "financial toxicity" Sep 26, 2018
<ѻýҕl>Anti-PD-L1 Drug Boosts Survival in Stage III NSCLCѻýҕl> New standard of care for patients with inoperable disease Sep 26, 2018
<ѻýҕl>Add-On Keytruda Boosts OS in Advanced Squamous Lung Cancerѻýҕl> Benefit seen across all subgroups, PD-L1 expression levels Sep 25, 2018